The Lymphoma Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), BMS (Gold), Johnson & Johnson (Gold), Takeda (Silver) and Galapagos (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
IWWM-11 2022 | The importance of genomics in Waldenström’s macroglobulinemia
Bruno Paiva, PhD, University of Navarra, Pamplona, Spain, briefly discusses the importance of genomic testing in Waldenström’s macroglobulinemia (WM), and further highlights how genomic testing can be used to identify patient response to various treatment approaches. This interview took place at the 11th International Workshop on Waldenström’s Macroglobulinemia (IWWM-11), held in Madrid, Spain.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
